Qi Guo, M.D., Ph.D. Department of Rehabilitation Medicine, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, 1500 Zhouyuan Road, Pudong New District, Shanghai, 201318, China, Fax: 86-22-8333-6977, E-mail:
J Nutr Health Aging. 2020;24(7):765-771. doi: 10.1007/s12603-020-1390-8.
The aim of the present study is to investigate the associations between the Asian Working Group for Sarcopenia (AWGS) sarcopenic definition, and its individual criteria, and risk of cardiovascular disease (CVD) and all-cause mortality in the Chinese elderly.
Longitudinal analysis of 1,264 participants aged 60 years or older at baseline (2013-2014) living in suburban areas, China. Sarcopenia was defined according to the recommended algorithm of AWGS. Muscle mass was measured by a direct segmental multifrequency bioelectrical impedance analysis. Muscle strength was assessed by handgrip strength, and physical performance measured via usual walking speed.
Cox proportional hazard models were used to assess the risk of CVD and all-cause mortality. After 40 months of follow-up, forty-eight deaths (4.2%) died in this cohort. The mortality rate with sarcopenia was 4.7% in men and 3.8% in women. After adjusting for potential confounders, the risk of all-cause death was 4.15 times higher in subjects with sarcopenia. Furthermore, low muscle mass (HR: 2.62, 95% CI 1.34-5.13) and low grip strength (HR: 5.79; 95% CI 2.28-14.71), but not walking speed, were found to be significantly associated with all-cause mortality. Risk of CVD mortality was significantly greater in sarcopenia. Low grip strength and low walking speed were associated with 11 times (HR: 11.03, 95% CI 1.58-77.02) and 13 times (HR: 13.02; 95% CI 1.18-143.78) higher risk of CVD mortality.
Sarcopenia and components of sarcopenia were associated with greater CVD and all-cause mortality. Pertinent prevention or rehabilitation programs projects should look to promote healthy aging in different types of sarcopenia group.
本研究旨在探讨亚洲肌少症工作组(AWGS)肌少症定义及其各项标准与中国老年人心血管疾病(CVD)和全因死亡率的相关性。
对居住在中国郊区的 1264 名年龄在 60 岁及以上的基线参与者(2013-2014 年)进行纵向分析。肌少症根据 AWGS 推荐的算法进行定义。通过直接节段多频生物电阻抗分析法测量肌肉量,通过握力评估肌肉力量,通过常规步行速度评估身体机能。
采用 Cox 比例风险模型评估 CVD 和全因死亡率的风险。在 40 个月的随访后,该队列中有 48 人(4.2%)死亡。男性肌少症的死亡率为 4.7%,女性为 3.8%。在调整了潜在混杂因素后,肌少症患者的全因死亡风险增加了 4.15 倍。此外,肌肉量低(HR:2.62,95%CI 1.34-5.13)和握力低(HR:5.79;95%CI 2.28-14.71)与全因死亡显著相关,但步行速度与全因死亡无关。肌少症与 CVD 死亡率显著相关。握力低和步行速度低与 CVD 死亡率分别增加 11 倍(HR:11.03,95%CI 1.58-77.02)和 13 倍(HR:13.02;95%CI 1.18-143.78)相关。
肌少症及其各组成部分与 CVD 和全因死亡率增加相关。相关的预防或康复项目应着眼于促进不同类型肌少症患者的健康老龄化。